Doing everything I can, even stopped hairloss progression, still unsatisfied.
    8/15/2026

    From the encyclopedia
    Finasteride β†’

    Prescription tablet (1 mg) that slowed hair loss versus placebo in two-year trials. Labels warn of sexual side effects that have continued after stopping, and of depression and suicidal thoughts; not for use in pregnancy.

    Minoxidil β†’

    A vasodilator used on the scalp (over the counter) and, off-label, as a low-dose prescription tablet for pattern hair loss.

    Dutasteride β†’

    A stronger DHT blocker than finasteride, approved for hair loss only in South Korea and Japan and off-label elsewhere, with the same class of side effects and a much longer washout.

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    πŸ’Š Finasteride (oral) 2 years
    πŸ’Š Minoxidil (oral) 5mg 1 year
    πŸ’Š Dutasteride (oral) 1.5mg 1.5 years
    β€’ Microneedling once a month
    β€’ Supplements 1 week
    the tone is 😞 negative with stabilization but no regrowth results.

    Other terms

    A 20-year-old male has been using finasteride, minoxidil, dutasteride, and microneedling to stop hair loss, achieving stabilization but no regrowth. He is considering a hair transplant and is struggling with the mental impact of his hair loss obsession.
    View this post in the Community β†’

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results

      research Safety concerns when using novel medications to treat alopecia

      23 citations , October 2018 in “Expert Opinion on Drug Safety”
      This review discusses the safety concerns associated with new treatments for non-scarring alopecias, highlighting that while these therapies such as JAK inhibitors and oral minoxidil show efficacy in hair regrowth, their safety profiles vary significantly, requiring careful consideration of benefits and risks.

      research Androgenetic alopecia: An update

      July 2023 in “JAAD International”
      This study describes androgenetic alopecia as a common non-scarring hair loss condition primarily influenced by genetic factors and androgen sensitivity, notably impacting psychosocial well-being, especially in females and younger males seeking treatment.

      research Management of androgenetic alopecia: a review

      January 2021 in “International Journal of Research in Dermatology”
      This source reviews treatments for androgenetic alopecia, highlighting that combining therapies generally improves effectiveness over single treatments, and discusses emerging drug-assisted delivery techniques aimed at increasing the efficiency of conventional drugs like minoxidil and finasteride.